Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)

Long-acting injectable cabotegravir (CAB-LA) is in advanced stages of clinical trials. Under the standard protocol, CAB-LA is injected into the gluteal muscle by a healthcare provider every eight weeks. To explore transgender women’s barriers and facilitators to tailored delivery strategies—includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rael, Christine Tagliaferri, Lopez-Ríos, Javier, McKenna, Stacey A., Das, Doyel, Dolezal, Curtis, Abascal, Elena, Carballo-Diéguez, Alex, Schnall, Rebecca, Hope, Thomas J., Bauermeister, José, Bockting, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254438/
https://www.ncbi.nlm.nih.gov/pubmed/34216284
http://dx.doi.org/10.1007/s10461-021-03357-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254438/
https://www.ncbi.nlm.nih.gov/pubmed/34216284
http://dx.doi.org/10.1007/s10461-021-03357-y

Ejemplares similares